SCHEMBL5533967

SCHEMBL5533967

Cc1cccc(C(=O)NC(=O)C(C)(C)C(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.51
KCNK3 O14649 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
KCNK9 Q9NPC2 3/20 0.50
KCNH2 Q12809 1/20 0.50
ATM Q13315 1/20 0.50
CYP2C19 P33261 1/20 0.50
ABCB1 P08183 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
STAT1 P42224 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14679306 0.84 HDAC8 (0.61) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL5539462 0.81 POLB (0.49) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL2382460 0.78 HDAC8 (0.57) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL27668893 0.77 SMN1; SMN2 (0.70) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL28744940 0.77 HDAC8 (0.69) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL21653856 0.75 SMN1; SMN2 (0.79) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL17140602 0.75 SMN1; SMN2 (0.54) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL18971666 0.75 ATM (0.59) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL31540297 0.75 HDAC8 (0.71) HDAC8HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL82080 0.75 HDAC8 (0.71) HDAC8HDAC6SMN1; SMN2KCNK3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed